Reported about 16 hours ago
Joseph Terranova, Senior Managing Director at Virtus Investment Partners, announced on CNBC that he has purchased Merck & Co., Inc. (NYSE:MRK), predicting a market shift towards quality stocks, particularly in healthcare. He noted that while the stock has faced challenges due to competition and market sentiment, it remains a strong investment opportunity. Impax US Sustainable Economy Fund highlighted Merck's resilience and contributions to healthcare despite recent weaknesses.
Source: YAHOO